Ignite Creation Date:
2025-12-25 @ 12:12 AM
Ignite Modification Date:
2025-12-25 @ 10:14 PM
Study NCT ID:
NCT00927758
Status:
COMPLETED
Last Update Posted:
2017-03-29
First Post:
2009-06-23
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Pilot Study to Examine the Post-Dose Changes in Exhaled Nitric Oxide (eNO) Following Treatment With Fluticasone Propionate (FP)/Salmeterol (SAL) Combination Product Advair
Sponsor:
Sandoz
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-06
Start Date Type:
None
Primary Completion Date:
2009-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-12
Completion Date Type:
ACTUAL
First Submit Date:
2009-06-23
First Submit QC Date:
None
Study First Post Date:
2009-06-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-04-22
Results First Submit QC Date:
None
Results First Post Date:
2014-09-08
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-03-27
Last Update Post Date:
2017-03-29
Last Update Post Date Type:
ACTUAL